Aligos Therapeutics Inc. (ALGS) Misses Q4 EPS by 191c
Tweet
Share
E-mailGet Alerts ALGS Hot Sheet
Join SI Premium – FREE
Aligos Therapeutics Inc. (NASDAQ: ALGS) reported Q4 EPS of ($1.91).
For earnings history and earnings-related data on Aligos Therapeutics Inc. (ALGS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Indaptus Therapeutics (INDP) files for 59M share offering by selling stockholders
- Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
